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SGK-1 (serum- and glucocorticoid-regulated kinase-1) is a stress-
induced serine/threonine kinase that is phosphorylated and activ-
ated downstream of PI3K (phosphoinositide 3-kinase). SGK-1
plays a critical role in insulin signalling, cation transport and
cell survival. SGK-1 mRNA expression is transiently induced
following cellular stress, and SGK-1 protein levels are tightly
regulated by rapid proteasomal degradation. In the present study
we report that SGK-1 forms a complex with the stress-associated
E3 ligase CHIP [C-terminus of Hsc (heat-shock cognate protein)
70-interacting protein]; CHIP is required for both the ubiquitin
modification and rapid proteasomal degradation of SGK-1. We
also show that CHIP co-localizes with SGK-1 at or near the endo-
plasmic reticulum. CHIP-mediated regulation of SGK-1 steady-
state levels alters SGK-1 kinase activity. These data suggest a
model that integrates CHIP function with regulation of the PI3K/
SGK-1 pathway in the stress response.
Key words: cell survival, C-terminus of Hsc70 interacting protein
(CHIP) E3 ligase, serum and glucocorticoid-regulated kinase-1
(SGK-1), stress response, phosphoinositide 3-kinase (PI3K),
ubiquitination.
INTRODUCTION
SGK-1 (serum- and glucocorticoid-regulated kinase-1) is an
‘AGC-family’ serine/threonine kinase that is regulated primarily
by transcriptional induction following various environmental
stimuli, as well as by post-translational phosphorylation, ubi-
quitin-modification and proteasomal degradation (reviewed in
[1]). Recent genetic experiments in Caenorhabditis elegans have
demonstrated that SGK-1 is also a critical mediator of insulin
signalling via phosphorylation and inactivation of the FOXO3a
homologue DAF-16 (decay-accelarating factor 16) [2,3]. SGK-1
mediates a potent survival signal downstream of PI3K (phospho-
inositide 3-kinase) activation and is required for glucocorticoid-
mediated breast epithelial cell survival [4,5]. In contrast with
Akt-1 (protein kinase B), with which SGK-1 shares approx. 50%
amino acid identity in its kinase domain, SGK-1 does not appear to
require plasma membrane targeting for activation; rather, SGK-1
is phosphorylated downstream of endogenous PI3K activity
regardless of its subcellular location [6]. Therefore the steady-
state levels of SGK-1 determine its overall kinase activity and
the rapid turnover of SGK-1 via proteasomal degradation plays
an important role in limiting SGK-1 activity following stress-
induced transcription [7].
Recently, the chaperone-dependent U-box ubiquitin ligase
CHIP [C-terminus of Hsc (heat-shock cognate protein) 70-inter-
acting protein] was identified as a protein quality control E3
ligase, whose role along with the Hsps (heat-shock proteins)
is to facilitate proper folding of client proteins [8,9]. Either
CHIP overexpression or underexpression can cause a defective
response to stress, suggesting that CHIP activity is critical for
cellular tolerance to adverse conditions. For example, CHIP
overexpression in recombinant Arabidopsis leads to slowed
growth at extremely high and low temperatures [10]. CHIP knock-
out mice show temperature sensitivity manifested by apoptosis in
multiple organs after exposure to a temperature of 42 ◦C [11].
In C. elegans, CHIP overexpression causes embryonic lethality,
and either CHIP knockout or knockdown causes developmental
arrest [12]. In summary, adequate CHIP activity functions to
balance proper folding of substrate proteins with their degradation
and is important in the cell’s adaptation to environmental chal-
lenges. CHIP has also been implicated as an E3 ligase contribut-
ing to the ubiquitination and degradation of the androgen receptor
[13], glucocorticoid receptor [14], ErbB2 [15] and the transcrip-
tion factor E2A [16]. In the present study we demonstrate that
CHIP forms a complex with SGK-1 resulting in ubiquitin modi-
fication and the proteasome-dependent degradation of SGK-1.
The results suggest a model in which SGK-1 activity is regulated,
at least in part, by CHIP-dependent protein turnover.
EXPERIMENTAL
Cell lines and plasmids
SK-BR-3 and MDA-MB-231 mammary epithelial cancer cell
lines, and wild-type (CHIP+/+) and CHIP knockout (CHIP−/−)
mouse fibroblasts immortalized with SV40 (simian virus 40) large
T-antigen were cultured as described previously [7,11]. Plas-
mids pLPCX/SGK-1–FLAG, pcDNA3.1/WT (WT, wild-type),
H260Q, K30A CHIP–Myc, pSiren/CHIP siRNA (small inter-
fering RNA) and pRBG4/HA–ubiquitin have been described
previously [7,15].
Transfections
SK-BR-3 cells were transiently co-transfected with the vec-
tors pLPCX/SGK-1–FLAG, pcDNA3.1/CHIP–Myc, pLPCX,
Abbreviations used: ALLN, N-acetyl-L-leucyl-L-leucylnorleucinal; CFTR, cystic fibrosis transmembrane conductance regulator; Hsc, heat-shock cognate
protein; CHIP, C-terminus of Hsc70-interacting protein; Ct, threshold cycle; ER, endoplasmic reticulum; GFP, green fluorescent protein; HRP, horseradish
peroxidase; Hsp, heat-shock protein; PI3K, phosphoinositide 3-kinase; SGK-1, serum- and glucocorticoid-regulated kinase-1; siRNA, small interfering
RNA; SV40, simian virus 40; TPR, tetratricopeptide repeat; WT, wild-type.
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pcDNA3.1 and/or pRBG4/HA–ubiquitin. For some experiments,
SK-BR-3 cells stably expressing SGK-1–FLAG and MDA-MB-
231 cells stably expressing H260Q CHIP–Myc were selected with
puromycin and neomycin respectively. In the experiments
with various amounts of SGK-1–FLAG or CHIP–Myc, a relevant
empty vector was used to supplement the total DNA amount. In
some experiments, ALLN (a peptide aldehyde, N-acetyl-L-leucyl-
L-leucylnorleucinal; 10 µM) or vehicle (ethanol) was added
overnight 36 h post-transfection.
Western blot analysis and immunoprecipitation
For Western blot analysis, cells were lysed in SDS/PAGE sample
buffer, and equal amounts of lysates were separated by SDS/
PAGE (12% gels). Resolved proteins were then immunoblotted
with anti-FLAG–HRP (horseradish peroxidase; Sigma), anti-
Myc–HRP (Santa Cruz Biotechnology), anti-SGK-1–HRP [5]
(conjugated using the EZ link conjugation kit; Pierce), anti-
Akt-1 (Cell Signaling Technology), anti-phospho-Akt-1 (S473;
Cell Signaling Technology) or anti-CHIP antibodies (a gift from
Dr L. Petrucelli and Dr M. Hutton, Mayo Clinic, Jacksonville,
FL, U.S.A.). An anti-rabbit HRP-conjugated secondary antibody
(1:5000; Santa Cruz Biotechnology) was used. Primary and HRP-
conjugated antibodies were diluted 1:1000. An anti-tubulin anti-
body (Calbiochem) was used at 1:10000, followed by an
anti-mouse HRP-conjugated secondary antibody diluted 1:10000
(Santa Cruz Biotechnology).
SGK-1–FLAG immunoprecipitation was performed using
equal amounts of cell lysates as described previously [7] with
minor modifications. Cells were lysed in a buffer containing
50 mM Tris/HCl (pH 7.5), 250 mM NaCl, 10 mM EDTA and 2 %
(v/v) Triton X-100; anti-FLAG M2–agarose (Sigma) was coated
with an excess of BSA prior to immunoprecipitation. Precipi-
tated proteins were eluted with 0.5 mg/ml FLAG–peptide
(Sigma), resolved on SDS/PAGE (10% gels), and immunoblotted
with anti-FLAG–HRP, anti-Myc–HRP, anti-CHIP (Calbiochem),
anti-SGK-1 or anti-Hsp70 (Stressgen) antibodies (1:1000) fol-
lowed by either anti-rabbit or anti-mouse HRP-conjugated
secondary antibodies (1:5000; Santa Cruz Biotechnology). CHIP
immunoprecipitation was performed essentially as described
above except Protein G–agarose (Invitrogen) coated with anti-
CHIP (Calbiochem) or rabbit IgG (Sigma) antibodies was used
for immunoprecipitation. Immunoblotting was performed with
anti-FLAG–HRP and anti-CHIP antibodies followed by an anti-
rabbit HRP-conjugated secondary antibody.
Immunofluorescence
At 48 h post-transfection with a plasmid encoding SGK-1 fused to
GFP (green fluorescent protein), CHIP–Myc and/or an ER (endo-
plasmic reticulum) marker pDsRed2-ER (Clontech), COS-7 cells
were seeded on coverslips and treated with ALLN (10 µM)
overnight. Cells were then fixed in 4 % paraformaldehyde,
blocked with 1 % foetal calf serum and permeabilized with 0.01%
saponin as described previously [4]. SGK-1 or DsRed2-ER was
then detected directly using GFP or DsRed2 fluorescence. CHIP–
Myc was detected using an anti-Myc antibody (1:100; Santa
Cruz Biotechnology) followed by an anti-mouse Alexa Fluor®
488-conjugated secondary antibody (1:1500, green; Molecular
Probes). Endogenous SGK-1 was detected using a C-terminus
chicken anti-SGK-1 antibody (1:100; US Biologicals) followed
by an anti-chicken Alexa Fluor® 488-conjugated secondary
antibody (1:1500). Endogenous CHIP was detected using a
rabbit anti-CHIP antibody (1:100; Calbiochem) followed by
an anti-rabbit Alexa Fluor® 488-conjugated secondary antibody
(1:1500). Cells were then examined at 630× magnification with a
Zeiss Axiovert 200 fluorescent microscope, using a cooled Orca
ER digital camera (Hamamatsu). Images were captured and ana-
lysed using Openlab® software. For co-localization studies, two
approaches were used. First, SGK-1–GFP and CHIP–Myc were
detected as described above, except that the anti-Myc antibody
was followed by an anti-mouse Alexa Fluor® 568-conjugated
secondary antibody (1:1500, red). Secondly, endogenous SGK-1
and CHIP were detected using chicken anti-SGK-1 (1:100) and
rabbit anti-CHIP (1:100) antibodies followed by an anti-chicken
Alexa Fluor® 488-conjugated secondary antibody (1:1500) or
an anti-rabbit Alexa Fluor® 568-conjugated secondary antibody
(1:1500) respectively.
In vivo ubiquitination assay
SK-BR-3 cells stably expressing SGK-1–FLAG were transfected
with plasmids encoding HA–ubiquitin (1 µg) and WT CHIP–
Myc (0.25–1 µg). SGK-1 was immunoprecipitated from equal
amounts of protein lysate as described previously [7]. SGK-1
species were then immunoblotted with either anti-HA or anti-
SGK-1 HRP-conjugated antibodies. CHIP expression in the
original cell lysates was detected using Western blotting with
the anti-Myc–HRP antibody (1:1000).
In vitro kinase assay
The in vitro kinase activity of SGK-1–FLAG expressed either in
the presence of WT CHIP–Myc or CHIP siRNA was determined
following immunoprecipitation from equal amounts of total cell
lysate by using a peptide called ‘Sgktide’ (KKRNRRLSVA) as a
substrate [17]. The experiment was performed six times for SGK-
1 in the presence of WT CHIP and four times for SGK-1 in the pre-
sence of CHIP siRNA. Ratios of SGK-1 activity in the presence
of WT CHIP–Myc or CHIP siRNA compared with SGK-1 activ-
ity alone were determined. Values are expressed as the means +−
S.E.M. Student’s t test was used for statistical evaluation and
P < 0.05 was considered significant. Equal volumes of residual
beads from the kinase assay were boiled in sample buffer, run on
SDS/PAGE and then probed for SGK-1 using Western blot ana-
lysis. The expression of CHIP and tubulin from equivalent
amounts of total cell lysates was detected using appropriate anti-
bodies.
Apoptosis assay
SK-BR-3 cells stably expressing SGK-1–FLAG were transiently
transfected with a plasmid encoding CHIP siRNA for 24 h and
then treated with UV (100 J/m2). Cells were fixed 48 h after UV-
treatment using 4% formaldehyde and stained with anti-(cleaved
caspase 3) Alexa Fluor® 488-conjugated antibody according to
the manufacturer’s protocol (Cell Signaling Technology). Flow
cytometry analysis of 10000 cells was performed on a four-
colour FACSCalibur equipped with an argon-ion laser (488 nm
excitation) and CellQuest software (Becton Dickinson). Cells
were gated using forward- and side-scatter properties and fluor-
escence intensity. The quantification of cleaved caspase-3-
positive populations was performed using FlowJo 8.0.1 software.
Each experiment was performed in triplicate; results are presented
as means +− S.E.M.
SGK-1 mRNA stability assay
CHIP+/+ and CHIP−/− mouse lung fibroblasts were treated with
5 µg/ml of actinomycin D to inhibit transcription, and the cells
were collected 0.5, 1, 1.5, 2, 3 and 4 h after treatment. Total
mRNA was isolated using the RNeasy mini kit (Qiagen) and was
then transcribed to cDNA with a TaqMan reverse transcription
c© 2006 Biochemical Society
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kit using a random hexamer primer (Applied Biosystems).
Real-time PCR of mouse SGK-1 and Actb (β-actin) cDNAs was
performed in triplicate with ABI Prism 7700 or 7300 instruments
(Applied Biosystems) using the SYBR® Green PCR master
mix (Applied Biosystems). The following primers were used:
SGK-1 sense 5′AGGCCCATCCTTCTCTGTTT 3′ and anti-
sense 5′TTCACTGCTCCCCTCAGTCT 3′, and Actb sense 5′AA-
TGGGGTACTTCAGGGTCA 3′ and antisense 5′GATATCGC-
TGCGCTGGTC 3′. The Ct (threshold cycle) values for SGK-1
and Actb were calculated from the obtained standard curves, and
SGK-1 Ct values were then normalized to the Ct value for Actb. To
detect genomic DNA contamination, real-time PCR was also per-
formed in mRNA control samples in the absence of reverse tran-
scriptase during cDNA synthesis. Each experiment was performed
at least three times, and results are reported as means +− S.E.M.
RESULTS
CHIP E3 ligase activity demonstrates an inverse correlation
with SGK-1 steady-state levels
During a candidate search for an E3 ligase that targets SGK-1
for degradation, we examined the effect of ectopically expressed
WT or mutant CHIP proteins on steady-state SGK-1 levels.
Figure 1(A) is a diagram of CHIP depicting the location of the
mutations used in the present study. A U-box domain mutation,
H260Q, renders CHIP unable to bind its cognate E2 ligase and is
therefore inactive as an E3 ligase [15]. A TPR (tetratricopeptide
repeat) domain mutation, K30A, renders CHIP unable to bind
Hsp/Hsc70, thereby indirectly abolishing the E3 ligase activity of
CHIP [14,15]. An equal number of SK-BR-3 breast cancer cells
were transiently transfected with a plasmid encoding SGK-1–
FLAG or in combination with increasing amounts of plasmid
DNA encoding WT, H260Q or K30A CHIP–Myc. Parallel
cell cultures were incubated in the presence or absence of
the proteasome inhibitor ALLN; SGK-1 and CHIP steady-state
protein levels were determined by Western blot. Figure 1(B)
shows that SGK-1 steady-state levels were barely detectable
in the absence of ALLN, although protein levels accumulated
following ALLN treatment consistent with proteasome-mediated
degradation as shown previously [7]. When WT CHIP was co-
expressed, SGK-1 steady-state levels accumulated slightly in
the presence of ALLN (Figure 1C, top panels). Interestingly,
SGK-1 protein expression decreased as WT CHIP expression
increased, suggesting that proteasome inhibition was not sufficient
to override augmented SGK-1 turnover. This may be due to the
incomplete inhibition of the proteasome by ALLN [18].
H260Q CHIP is a dominant-negative protein due to a single
point mutation that abrogates E2 ligase interaction and yet allows
substrate sequestration from endogenous CHIP [15]. As expected,
increasing amounts of H260Q CHIP correlated with increased
SGK-1 steady-state levels, best demonstrated in the presence
of ALLN. In the absence of ALLN, SGK-1 steady-state levels
were also increased with the highest expression of H260Q CHIP
(Figure 1C, middle panels). These results suggest that CHIP’s
U-box domain and its accompanying E2 ligase are likely to
be involved in the rapid turnover of SGK-1 [7]. Interestingly,
expression of K30A CHIP, a mutant CHIP protein unable to bind
Hsp/Hsc70, resulted in slightly increased SGK-1 levels in the
presence of ALLN (Figure 1C, bottom panels). This suggests that
the chaperone-deficient K30A CHIP may also interfere with SGK-
1 degradation, although not as efficiently as the H260Q mutant
CHIP protein.
To study further the relationship between CHIP and SGK-1,
we examined cells transfected with a fixed amount of ectopic
Figure 1 CHIP E3 ligase activity promotes the down-regulation of SGK-1
(A) Domain structure of WT and mutant CHIP. (B) SK-BR-3 cells were co-transfected with
SGK-1–FLAG DNA (1.5 µg) and pcDNA3.1 (1.5 µg). At 36 h post-transfection, ALLN or
vehicle (ethanol) were added overnight. The cells were lysed and subjected to immunoblotting
with anti-FLAG antibodies to detect SGK-1. (C) The plasmids encoding SGK-1 (1.5 µg)
and increasing amounts of WT, H260Q and K30A CHIP–Myc (0.1, 0.2, 0.38 and 0.75 µg)
were expressed in SK-BR-3 cells. ALLN was added as above, and the cells were lysed and
subjected to Western blot analysis with the indicated antibodies. (D) Increasing amounts
of SGK-1–FLAG-encoding plasmids (0.5, 1.0 and 2.0 µg) were co-transfected with WT and
mutant CHIP constructs into SK-BR-3 cells and SGK-1 expression was determined by Western
blot analysis. (E) MDA-MB-231 cells stably expressing H260Q CHIP or the empty pcDNA3.1
vector were treated with ALLN or vehicle overnight and then examined by Western blotting for
endogenous SGK-1 and ectopic CHIP expression. IB, immunoblot.
WT or mutant CHIP and increasing amounts of the SGK-1–
FLAG plasmid. Without ectopic CHIP expression, SGK-1 steady-
state levels increased according to transfected DNA amounts, and
were further increased by ALLN (Figure 1D, top panels). As
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expected, SGK-1 levels decreased with WT CHIP co-expression
and were stabilized by ALLN treatment. In contrast, H260Q CHIP
co-expression dramatically increased steady-state SGK-1 levels
even in the absence of ALLN, further suggesting that H260Q
CHIP interferes with ubiquitin-mediated degradation of SGK-1.
Expression of the K30A CHIP mutant did not significantly change
SGK-1 levels in comparison with expression of the empty vector
(Figure 1D, bottom panels). This suggests that the K30A CHIP
dose-dependent stabilization of SGK-1 observed in Figure 1(C)
may be due to an indirect mechanism (e.g. heterodimerization
and inactivation of endogenous CHIP when expressed at high
concentrations) rather than to the binding and sequestration of
SGK-1 from endogenous CHIP [19].
We then asked whether the E3 ligase activity of CHIP mediates
down-regulation of endogenous SGK-1. To this end, we attempted
to generate MDA-MB-231 breast cancer cells stably expressing
WT or H260Q CHIP. However, stable overexpression of WT
CHIP was not tolerated during the antibiotic selection process
despite multiple attempts. This phenomenon is reminiscent of the
temperature intolerance seen in Arabidopsis stably overexpressing
WT CHIP [10]. Stably expressing H260Q CHIP cells were
successfully generated. Pools of these cells were starved of
all growth factors overnight and then stimulated with 1 µM
dexamethasone for 16 h to induce endogenous SGK-1 expression.
As shown in Figure 1(E), stable expression of H260Q CHIP
dramatically increased endogenous SGK-1 steady-state levels,
even in the absence of ALLN. These results suggest that the E3
ligase activity of CHIP contributes to rapid SGK-1 turnover, and
that constitutively increased CHIP activity is not compatible with
cell survival.
SGK-1 associates with CHIP in vivo
To determine whether CHIP interacts with SGK-1 in vivo, we
co-transfected SK-BR-3 cells with Myc-tagged WT, H260Q or
K30A CHIP and SGK-1–FLAG. SGK-1–FLAG was immuno-
precipitated with an anti-FLAG antibody, and co-precipitating
proteins were analysed by immunoblotting. There was no back-
ground CHIP co-precipitated in the absence of SGK-1–FLAG
(Figure 2A, lanes 1 and 2), and the anti-FLAG antibody efficiently
precipitated SGK-1–FLAG (Figure 2A, lanes 3 and 4). WT CHIP
co-precipitated with SGK-1, but only in the presence of ALLN
(Figure 2A, lane 6). Presumably, proteasome inhibition by
ALLN allows SGK-1–CHIP complexes to accumulate to a level
sufficient for detection; in the absence of proteasome inhibition,
SGK-1–CHIP complexes may not be detectable owing to their
rapid degradation. In contrast with WT, H260Q CHIP co-pre-
cipitated both in the presence and absence of ALLN, suggesting
that the lack of E3 ligase activity allowed the accumulation of
H260Q SGK-1–CHIP complexes (Figure 2A, lanes 7 and 8).
K30A CHIP, which is impaired in chaperone binding, did not co-
precipitate with SGK-1, suggesting that Hsp binding to CHIP is
required for the SGK-1–CHIP interaction (Figure 2A, lanes 9 and
10). It is not clear at this point whether CHIP directly interacts
with SGK-1 or whether the CHIP–SGK-1 interaction is mediated
by Hsp tethering of the two proteins (Figure 7).
The chaperones Hsc70 and Hsp70, in association with CHIP,
are known to participate in protein quality control. When pro-
teins are misfolded, Hsp70 replaces Hsp90 in a complex with
client proteins and interacts with CHIP via its TPR-domains
[15]. Therefore the CHIP–Hsp70 complex can target misfolded
proteins for degradation by the proteasome. Because SGK-1
appeared to co-precipitate with CHIP, we next examined whether
or not Hsp70 is part of the SGK-1–CHIP complex. SK-BR-3
cells stably expressing SGK-1–FLAG were transfected with a
Figure 2 CHIP and Hsp/Hsc70 interact with SGK-1 in vivo
(A) SGK-1–FLAG was expressed in SK-BR-3 cells and immunoprecipitated followed by Western
blotting in the presence or absence of WT and mutant CHIP–Myc expression. (B) SGK-1
was immunoprecipitated from SK-BR-3 cells stably expressing SGK-1–FLAG and transiently
expressing WT CHIP–Myc. Immunoblotting was then performed to detect SGK-1 and Hsp/Hsc70
or CHIP using the appropriate antibody. (C) WT or H260Q CHIP was immunoprecipitated from
SK-BR-3 cells transiently transfected with SGK-1–FLAG and CHIP constructs and subjected to
Western blot analysis to detect SGK-1. IB, immunoblot.
plasmid encoding WT CHIP, treated with or without ALLN, and
lysates were subjected to FLAG-immunoprecipitation followed
by immunoblotting with an anti-CHIP or an anti-Hsp70
antibody. In this experiment, the anti-CHIP antibody detects both
endogenous and ectopic CHIP co-precipitated with SGK-1 even
in the absence of ALLN, suggesting that stable overexpression of
SGK-1 increased the ability to detect SGK-1–CHIP complexes
(Figure 2B, left panel compared with Figure 2A, lane 5). Hsp70
and Hsc70 were also detected in the presence of ectopic CHIP,
suggesting that the amount of Hsp/Hsc70 in the complex with
SGK-1 may be dependent on CHIP expression levels. In the
presence of ALLN, Hsp70 co-precipitated with SGK-1 even
though endogenous CHIP could not be detected. However, with
additional ectopic CHIP expression, both Hsp70 and CHIP were
detectable (Figure 2B, right panel).
To further characterize SGK-1–CHIP interactions, we per-
formed the reciprocal immunoprecipitation of ectopic WT or
H260Q CHIP in SK-BR-3 cells transiently expressing SGK-1–
FLAG. Both WT and H260Q CHIP were specifically immuno-
precipitated with an anti-CHIP antibody (Figure 2C, upper panel,
lanes 2, 4, 6 and 8). As expected, SGK-1 co-precipitated with both
WT and H260Q CHIP, while a control IgG did not precipitate
either CHIP or SGK-1 (Figure 2C, bottom panel). Taken together,
these results suggest that SGK-1 can form a complex with Hsp/
Hsc70 and CHIP that facilitates the chaperone-dependent pro-
teasome-mediated degradation of SGK-1.
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CHIP mediates SGK-1 protein down-regulation and ubiquitin
modification
We next asked whether the absence of CHIP would increase
endogenous SGK-1 steady-state levels. To address this, we ex-
amined SGK-1 protein levels in CHIP+/+ or CHIP−/− mouse
lung fibroblasts immortalized with SV40 large T-antigen [11].
Equal numbers of cells were treated with or without ALLN
and then harvested in SDS/PAGE sample buffer. As shown in
Figure 3(A), SGK-1 was barely detectable in the absence of
ALLN but accumulated following ALLN treatment in CHIP+/+
cells, whereas in CHIP−/− cells, there was significantly more
endogenous SGK-1 expressed without ALLN. In addition, SGK-1
steady-state levels did not change significantly in CHIP−/− cells
following ALLN treatment, further suggesting that endogenous
CHIP down-regulates SGK-1 via a proteasome-dependent pro-
cess. Interestingly, neither total Akt-1 nor phosphorylated Akt-1
(phosphorylated on Ser473) levels changed in CHIP−/− cells,
suggesting that CHIP-mediated down-regulation is relatively
specific to SGK-1.
We next determined whether differences in mRNA stability
might contribute to the increased SGK-1 protein expression
observed in CHIP−/− cells. CHIP+/+ and CHIP−/− cells were
treated with actinomycin D for various periods of time, RNA
was isolated and SGK-1 mRNA was quantified using real-time
PCR. As shown in Figure 3(B), the stability of SGK-1 mRNA in
both CHIP+/+ and CHIP−/− cells was similar, suggesting that the
increased SGK-1 protein levels observed in CHIP−/− cells are due
to a post-transcriptional mechanism rather than to differences in
stability of SGK-1 mRNA.
To further study the effect of CHIP knockdown on SGK-1
steady-state levels in another cell line, we examined endogenous
SGK-1 protein levels in SK-BR-3 cells stably transfected with
CHIP siRNA. As shown in Figure 3(C) (middle panel and
histogram), endogenous CHIP levels decreased by approx. 50 %
following CHIP siRNA expression, and endogenous SGK-1 levels
increased moderately (Figure 3C, upper panel). The relatively
small accumulation of SGK-1 following CHIP knockdown in
SK-BR-3 cells compared with CHIP−/− cells is probably due to
the incomplete knockdown of CHIP with siRNA.
Finally we asked whether SGK-1 is an in vivo substrate for
CHIP-mediated E3 ubiquitin ligase activity. Increasing amounts
of WT CHIP and a single concentration of the HA–ubi-
quitin plasmids were co-transfected into SK-BR-3 cells stably
expressing SGK-1–FLAG. Following immunoprecipitation of
SGK-1–FLAG, ubiquitinated SGK-1 was detected with an anti-
HA antibody. Ubiquitinated SGK-1 species increased following
WT CHIP overexpression and further increased with greater WT
CHIP expression (Figure 3D, lane 2 compared with lanes 3–5).
Concurrently, unmodified SGK-1 steady-state levels decreased
slightly, providing additional evidence that CHIP targets SGK-1
for degradation via ubiquitin modification (Figure 3D, lanes 3,
4 and 5). Taken together, these experiments suggest that CHIP
E3 ligase activity decreases SGK-1 steady-state levels via a
proteasome-dependent pathway.
CHIP and SGK-1 co-localize at the ER
SGK-1 has been shown by biochemical fractionation to exhibit
approximately equivalent cytoplasmic and membrane-associated
subcellular localization [7]. Interestingly, the membrane-asso-
ciated fraction of SGK-1 is highly polyubiquitinated, whereas
the soluble cytoplasmic fraction is largely unmodified by ubi-
quitin [7]. CHIP has also been shown to be predominantly cyto-
plasmic, with some localization to the ER [11,20]. We therefore
Figure 3 CHIP is required for SGK-1 protein stability and ubiquitin
modification
(A) CHIP+/+ and CHIP−/− mouse fibroblasts were treated overnight with ALLN or vehicle, lysed,
and then examined by Western blotting for endogenous SGK-1, CHIP, Akt-1 and phospho-Akt-1
proteins. (B) Mouse fibroblasts were treated with 1 µg/ml of actinomycin D for indicated time
periods. Total RNA was then isolated, and SGK-1 mRNA was quantified using quantitative
real-time PCR. The ratio of SGK-1 to Actb mRNAs was calculated at each time point, and then
expressed as a percentage of SGK-1/Actb ratio at 60 min. Data points represent the means
for three independent experiments. S.E.M. and the calculated half-life are shown. (C) SK-BR-3
cells were stably transfected with CHIP siRNA and subjected to immunoblotting to examine
endogenous SGK-1, CHIP and tubulin levels. The representative immunoblot from one of three
independent experiments is shown. Quantification of the representative immunoblot shows CHIP
protein levels relative to those of tubulin. (D) SK-BR-3 cells stably expressing SGK-1–FLAG
were transfected with HA–ubiquitin plasmid and increasing amounts of WT CHIP plasmid.
Immunoprecipitated SGK-1 was subjected to immunoblotting with anti-SGK-1 and anti-HA
antibodies. CHIP expression was evaluated by Western blot analysis in the total lysate. The blot
is representative of three independent experiments. IB, immunoblot.
hypothesized that CHIP and SGK-1 might co-localize to a mem-
branous compartment in the cytoplasm, where SGK-1 is sub-
sequently ubiquitinated. To test this hypothesis, we first
c© 2006 Biochemical Society
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Figure 4 SGK-1 and CHIP co-localize to the ER
(A) COS-7 cells were transfected with the plasmids encoding SGK-1–GFP, WT-CHIP–Myc or both (top, middle and bottom panels respectively) and the ER marker, pDsRed2-ER (which encodes
calreticulin and an ER-retention signal fused to DsRed2). CHIP was detected using an anti-Myc antibody and a secondary anti-mouse antibody conjugated to Alexa Fluor® 488 (middle and bottom
panels). (B) COS-7 cells were transfected with pDsRed2-ER vector (top and middle panels). Endogenous SGK-1 was detected with an anti-SGK-1 chicken antibody followed by an anti-chicken Alexa
Fluor® 488-conjugated secondary antibody (top and bottom panels). Endogenous CHIP was detected with anti-CHIP rabbit antibody followed by anti-rabbit Alexa Fluor® 488-conjugated secondary
antibody (middle panel) or anti-rabbit Alexa Fluor® 568-conjugated secondary antibody (bottom panel). Co-localization is shown in the merge column in yellow.
determined whether either CHIP or SGK-1 co-localizes with
an ER marker, calreticulin. SGK-1–GFP or CHIP–Myc was co-
transfected into COS-7 cells along with a plasmid encoding the
ER-targeting sequence of calreticulin and an ER-retention se-
quence (KDEL) fused to DsRed2 (pDsRed-ER; Clontech). CHIP–
Myc was detected using an anti-Myc antibody followed by an anti-
mouse Alexa Fluor® 488-conjugated secondary antibody (green).
SGK-1–GFP appeared to co-localize with the ER-targeted red
marker in the majority of the cells (Figure 4A, upper panel),
although a mitochondrial localization pattern was also seen
in approx. 15% of SGK-1–GFP-expressing cells (results not
shown). In agreement with a previous report [20], CHIP–Myc
also localized to the ER (Figure 4A, middle panel).
In order to determine the extent of co-localization, SGK-1–
GFP and CHIP–Myc were co-transfected into COS-7 cells, and
CHIP was detected as indicated above, except that the anti-Myc
antibody was followed by an anti-mouse Alexa Fluor® 568-
conjugated secondary antibody (red). SGK-1–GFP (green) and
CHIP–Myc (red) showed co-localization (yellow), although there
was clearly some cytoplasmic SGK-1–GFP that did not appear
to be associated with CHIP–Myc (Figure 4A, bottom panel).
These results suggest that ectopic SGK-1 and CHIP co-localize
at or near the ER, and provide an explanation for our previous
findings that polyubiquitin modified SGK-1 is found exclusively
in a membrane-associated fraction [7].
We further examined whether localization of endogenous SGK-
1 and CHIP is similar to that of ectopically expressed proteins.
We expressed the pDsRed2-ER marker in COS-7 cells and then
detected endogenous SGK-1 with a chicken anti-SGK-1 antibody
followed by an anti-chicken Alexa Fluor® 488-conjugated IgG.
The localization pattern of endogenous SGK-1 (Figure 4B,
top panel) resembled the localization of ectopic SGK-1–GFP.
Endogenous CHIP was probed with a rabbit anti-CHIP antibody
followed by an anti-rabbit Alexa Fluor® 488-conjugated IgG. We
found that endogenous CHIP (green) also localized to the ER (red)
in a pattern similar to that of ectopically expressed CHIP–Myc
(Figure 4B, middle panel). In co-localization studies, which were
performed with the antibodies mentioned above except that the
anti-chicken IgG was conjugated to Alexa Fluor® 488 and anti-
rabbit to Alexa Fluor® 568, endogenous SGK-1 (green) and endo-
genous CHIP (red) also showed significant co-localization
(yellow; Figure 4B, bottom panel).
CHIP expression levels alter SGK-1 kinase activity in vitro
We then asked whether, as a consequence of regulating SGK-1
expression, CHIP affects overall SGK-1 kinase activity. To
address this, we immunoprecipitated SGK-1–FLAG from norm-
ally growing unstimulated SK-BR-3 cells transiently transfected
with WT CHIP or CHIP siRNA and measured SGK-1 kinase
activity using an in vitro kinase assay (Figure 5). Following
WT CHIP expression, SGK-1 kinase activity decreased relative
to SGK-1 activity in the absence of ectopic CHIP (Figure 5A,
left-hand panel). Consistent with our previous results, steady-
state SGK-1 levels also decreased (Figure 5B, left-hand panel).
In contrast, knockdown of CHIP was associated with slightly
increased SGK-1 activity in the absence of serum stimulation
(Figure 5A, right-hand panel) and increased SGK-1 expression
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Figure 5 CHIP expression levels regulate SGK-1 in vitro kinase activity
(A) Following transient transfection of SK-BR-3 cells with the plasmids encoding SGK-1–FLAG
and either CHIP–Myc or CHIP siRNA, SGK-1 was immunoprecipitated and used in an in vitro
kinase assay as previously described [17]. Ratios of SGK-1 activity in the presence of CHIP–Myc
or CHIP siRNA to SGK-1 activity alone are shown as a mean of six or four independent experiments
respectively +− S.E.M. *P < 0.05 compared with SGK-1 activity alone. (B) Following the kinase
assay, levels of immunoprecipitated SGK-1 were determined by Western blot analysis. In the
total lysates, ectopic CHIP was detected with an anti-Myc antibody, while endogenous CHIP
and tubulin were determined using an anti-CHIP and an anti-tubulin antibody respectively.
IP, immunoprecipitation; IB, immunoblot.
(Figure 5B, right-hand panel). These results suggest that CHIP
modulates SGK-1 expression and kinase activity even in the
absence of PI3K stimulation, consistent with previous models
suggesting a primary role for SGK-1 expression levels in
determining SGK-1 kinase activity [6].
CHIP functions in both SGK-1-dependent and -independent cell
survival pathways
SGK-1 has been shown to play a prominent anti-apoptotic role in
breast cancer cells subjected to cellular stresses including chemo-
therapy [5], growth factor withdrawal [4,6] and UV [6]. CHIP
has also been shown to regulate the stress response, and
CHIP knockout causes increased apoptosis in mouse fibroblasts
and physiological intolerance to heat shock in mice [11]. In
the present study, because we observed that CHIP expression
inversely correlates with SGK-1 steady-state levels and activity,
we examined the relative roles of CHIP and SGK-1 expression in
mediating cell survival. We exposed SK-BR-3 cells expressing
CHIP siRNA, SGK-1–FLAG or both to UV and determined
the percentage of apoptotic cells positively staining for cleaved
caspase-3 using flow cytometry. The cells expressing ectopic
SGK-1 had approx. 40% less apoptosis than control cells (Fig-
ure 6A, white bar compared with black bar), suggesting a role for
SGK-1 in cell survival following UV damage. This observation
is similar to the anti-apoptotic effect of ectopically expressed
SGK-1 observed in non-tumorigenic rat mammary epithelial cells
following UV [6]. The representative scatter plots shown in
Figure 6 SGK-1 and CHIP have both overlapping and independent anti-
apoptotic roles
(A) SK-BR-3 cells stably expressing SGK-1–FLAG or empty vector were transiently transfected
with CHIP siRNA DNA. At 48 h post UV-irradiation (100 J/m2), the percentage of apoptotic cells
was determined using flow cytometric detection of cells staining for cleaved caspase-3 using the
respective Alexa Fluor® 488-conjugated antibody. Results represent the means of the positively
stained cell population +− S.E.M. for three independent experiments. (B) Representative flow
cytometric plots depict the percentage of cleaved caspase-3-positively stained cells in the
experimental groups.
Figure 6(B) illustrate the differences in cleaved caspase-3-positive
stained cells in the control compared with SGK-1-expressing
groups.
We also observed that despite the effect of CHIP siRNA on
increasing endogenous SGK-1 expression (experiment in Fig-
ure 3C), CHIP knockdown significantly increased apoptosis in
SK-BR-3 cells following UV stress (Figures 6A, grey bar com-
pared with black bar, and 6B). Therefore down-regulation of
CHIP appears to override the anti-apoptotic effect expected by
increasing endogenous SGK-1, suggesting that CHIP knockdown
also facilitates SGK-1-independent apoptotic pathways. We next
examined whether additional ectopic SGK-1 expression would
decrease apoptosis following CHIP siRNA, reasoning that more
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SGK-1 expression would provide a enhanced pro-survival effect.
Indeed, we found that additional SGK-1 expression partially
rescued apoptosis caused by CHIP knockdown (Figures 6A,
hatched bar compared with grey bar, and 6B). However, SGK-1
ectopic expression in the presence of CHIP siRNA did not protect
cells from apoptosis as effectively as expression of ectopic SGK-1
alone (Figure 6A, hatched bar compared with white bar). This
suggests that down-regulation of CHIP affects both SGK-1-
dependent and SGK-1-independent anti-apoptotic pathways. This
model is supported by previous findings that CHIP knockdown
increases apoptosis via up-regulation of the apoptosis signal-
regulating kinase 1 [21]. In summary, the study of the relative
effects of CHIP compared with SGK-1 expression on apoptosis
suggests that CHIP functions in multiple ways to fine-tune the
cellular response to stress; the multitude of CHIP substrates
identified to date suggests a complex regulation between CHIP
and both pro- and anti-apoptotic proteins.
DISCUSSION
It has been well-documented that SGK-1 is transcriptionally up-
regulated following various stress stimuli, thereby providing a
transient increase in SGK-1 protein levels and a survival signal to
the cell [5,6]. However, the stress-induced expression and activity
of SGK-1 are usually not sustained because of the short half-life
of both its mRNA and protein product [7]. Additional mechanisms
that limit the duration of SGK-1 activity following stress induction
are not completely understood. In the present study we show
that the E3 ligase CHIP plays an important role in the rapid
protein degradation of SGK-1. The co-localization of SGK-1
and CHIP at the ER is consistent with our recent finding that
SGK-1 degradation requires a hydrophobic amino-acid sequence
(amino acids 19–24) that is also required for the localization
of SGK-1 to the ER [22]. Interestingly, CHIP also targets sev-
eral other ubiquitin-modified stress-induced signalling proteins
including ErbB2 [15], CFTR (cystic fibrosis transmembrane
conductance regulator) [20], p53 [23], apoptosis signal-regulating
kinase 1 [21] and c-Raf [24]. Our findings further extend the
function of CHIP to the regulation of the PI3K pathway. Although
CHIP expression down-regulates SGK-1 steady-state levels and
activity, CHIP knockdown results in increased SGK-1 expression
and activity. Although SGK-1 and Akt-1 are closely related
kinases, we found that Akt-1 protein levels and phosphorylation
were not affected in CHIP knockout cells, suggesting that CHIP-
mediated regulation of the PI3K pathway is relatively specific to
SGK-1.
CHIP and related chaperone-associated proteins have been
implicated in protein quality control in association with the ER
[20]. We now report that both CHIP and SGK-1 co-localize to the
ER, suggesting that CHIP, in complex with Hsps, assists in pro-
per SGK-1 folding. This folding may allow for full activation
of SGK-1 similar to the regulatory mechanism of the binding of
Akt-1 to phosphatidylinositol 3,4,5-trisphosphate prior to its ac-
tivation as a kinase.
Both SGK-1 and CHIP have been implicated in the response to
cellular stress. SGK-1 transcriptional up-regulation is required for
PI3K-mediated cell survival signalling following hyperosmotic
shock, temperature stress, UV irradiation and endocrine factor
stimulation [5,6]. SGK-1 overexpression has been associated with
renal, lung and cardiac pathophysiology via regulation of ion
channels (reviewed in [25]). For example, SGK-1 increases the
abundance and activity of the epithelium sodium channel and
the potassium channel ROMK1 [26,27]. This enhanced activ-
ity appears to increase sodium reabsorption, potassium secretion,
water retention, and as a result, blood pressure. In lung tissue,
SGK-1 up-regulates epithelium sodium channel and CFTR
[28,29], both of which enhance fluid secretion and mucus clear-
ance in the lung. In cystic fibrosis, fluid secretion and mucus
clearance are impaired due to defective CFTR and increased
sodium channel activity mediated, in part by SGK-1 [29].
In cardiac muscle, SGK-1 up-regulates the voltage-gated
sodium channel SCN5A [30,31] and the potassium channels
KCNE1/KCNQ1 and Kv 4.3 [32,33], which participate in the gen-
eration and propagation of cardiac potential and repolarization.
The importance of SGK-1 in the heart has also been demonstrated
in cardiomyocytes that are subjected to hypoxia as well as mech-
anical, hormonal and oxidative stresses [34,35,36]. All of these
factors increase SGK-1 expression, which can mediate phos-
phorylation of GSK3β [37], CTGF (connective tissue growth
factor) [35,37] and ANF (atrial natriuretic factor), a marker of
the hypertrophic response [34]. Deregulation of SGK-1-mediated
events is likely to underlie cardiac myocyte hypertrophy and
myocardial fibrosis. In addition, the pro-survival activity of
SGK-1 in cardiomyocytes following stress may further aggravate
hypertrophy [34]. These findings suggest a central role for
SGK-1 in the integrated regulation of sodium homoeostasis, fluid
secretion, blood pressure and heart function.
The exact role of CHIP in the response to physiological stress is
just beginning to be understood. Interestingly, CHIP and SGK-1
play similar roles in multiple diseases. For example, following
heat shock, CHIP contributes to cardiomyocyte survival via tri-
merization and transcriptional activation of HSF1 (heat-shock
factor 1), which in turn up-regulates Hsp70 protein levels [11,38].
CHIP then attenuates Hsp70 levels via ubiquitin modification,
allowing a recovery from stress [39]. The most striking illustration
of a global role for CHIP in the regulation of the stress response
comes from the recent study of the CHIP−/− mouse response to
cardiac ischaemia and reperfusion injury. Mice that lack CHIP
have decreased survival and an increased incidence of arrhythmias
and myocardial infarction during reperfusion. This pathology
is accompanied by impaired up-regulation of the chaperone
Hsp70 and increased apoptosis in cardiomyocytes and vascular
endothelial cells [40]. Like SGK-1, CHIP also participates in
maturation of the glycoprotein CFTR in epithelial cells, suggest-
ing that SGK-1-mediated activation of CFTR may also be regu-
lated by CHIP activity. In neurons, the chaperone and E3
ligase activities of CHIP regulate folding and degradation of the
misfolded polyglutamine proteins, tau and α-synuclein, thereby
preventing their aggregation [41–43]. This function links CHIP to
the neurodegenerative diseases Huntington’s disease, Parkinson’s
disease and Alzheimer’s disease; the list of neurodegenerative
diseases associated with CHIP is likely to increase as identification
of CHIP substrates grows. Interestingly, SGK-1 activity has also
been implicated in Parkinson’s disease and ALS (amyotrophic
lateral sclerosis) via regulation of glutamate transporters, ion
channels and increased neuronal cell survival [44].
In the present study we show for the first time that the PI3K/
SGK-1 signalling pathway appears to be regulated by the chaper-
one-dependent E3 ligase machinery. Under conditions that
enhance PI3K/SGK-1 signalling, such as glucocorticoid stimu-
lation or environmental stress, SGK-1 provides a strong survival
signal to epithelial cells (Figure 6). SGK-1 signalling can be either
down-regulated by the E3 ligase activity of CHIP or might remain
active if the SGK-1–CHIP interaction is compromised. Because of
the multifunctional nature of CHIP, distinguishing the regulation
of SGK-1 by CHIP from the other roles of CHIP will require
mapping the interaction domains of both SGK-1 and CHIP.
In summary, the activity of both CHIP and SGK-1 appear to
be important components of the physiological stress response in
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Figure 7 Proposed model of CHIP-mediated regulation of SGK-1 function
SGK-1 is induced as part of the stress response and is then available to be phosphorylated and activated downstream of PI3K. Upon either a direct or indirect interaction with CHIP at or near the ER,
we hypothesize that SGK-1 becomes properly folded and fully active, thereby promoting cell survival. CHIP-mediated ubiquitin (Ub) modification of SGK-1, however, also allows for the subsequent
rapid degradation and return to baseline of SGK-1 levels.
epithelial cells, and in the present study we demonstrate a physical
and functional link between these two proteins. We propose that
under conditions such as DNA damage, SGK-1 expression and
activity are up-regulated. CHIP–Hsp70–Hsc70 complexes might
then assist in the proper folding and full activation of SGK-1
followed by ubiquitin modification and increased SGK-1 turn-
over, thereby moderating the stress response (Figure 7). Because
continuous SGK-1 up-regulation could be deleterious for cells,
SGK-1 expression probably requires a mechanism for negative
regulation that includes ubiquitin modification and proteasomal
degradation. Deregulated SGK-1 expression has been associated
with breast cancer [45,46] and diabetic nephropathy [47]. The re-
lationship between SGK-1 and CHIP in those diseases associated
with physiological stress (e.g. DNA damage, oxidative damage
and hyperosmolarity) remains the subject of future studies.
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